YieldMax MRNA Option Income Strategy ETF
MRNY
11 hedge funds and large institutions have $37.2M invested in YieldMax MRNA Option Income Strategy ETF in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 7 closing their positions.
118% more capital invested
Capital invested by funds: $17M → $37.2M (+$20.1M)
4.24% more ownership
Funds ownership: 25.29% → 29.53% (+4.2%)
21% less funds holding
Funds holding: 14 → 11 (-3)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
57% less call options, than puts
Call options by funds: $46K | Put options by funds: $108K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Tidal Investments
Milwaukee,
Wisconsin
|
+$14M |
| 2 |
Jane Street
New York
|
+$1.5M |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$1.03M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.02M |
| 5 |
MCA
McGuire Capital Advisors
Bethany,
Oklahoma
|
+$28.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$925K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$246K |
| 3 |
KPWS
Kestra Private Wealth Services
Austin,
Texas
|
-$187K |
| 4 |
HF
HRT Financial
New York
|
-$152K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$7.22K |
MRNY Hedge Fund Activity: Q1 2026 in Review
11 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in YieldMax MRNA Option Income Strategy ETF (MRNY) for Q1 2026, worth a combined $37.2M — up 118% from $17M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of MRNY and 5 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 4 added.
The largest buyer was Tidal Investments, adding an estimated $14M. The largest seller was Bank of America, exiting entirely with an estimated $925K sold.
- 11 institutional investors held YieldMax MRNA Option Income Strategy ETF (MRNY) as of Q1 2026, down from 14 in Q4 2025.
- Funds reported $37.2M of YieldMax MRNA Option Income Strategy ETF stock for Q1 2026, up 118% quarter-over-quarter.
- 5 funds opened new YieldMax MRNA Option Income Strategy ETF positions in Q1 2026 and 7 closed out, a net change of -2 holders.
- The largest YieldMax MRNA Option Income Strategy ETF buyer in Q1 2026 was Tidal Investments, an estimated $14M added.
- The largest YieldMax MRNA Option Income Strategy ETF seller in Q1 2026 was Bank of America, an estimated $925K sold.
Based on aggregated 13F filings for Q1 2026.